Target intelligence / Profile preview

High mobility group nucleosomal binding domain 3 pseudogene 1 (HMGN3P1)

Target
HMGN3P1
Molecular classification
Other (Processed pseudogene)
01

Overview

High mobility group nucleosomal binding domain 3 pseudogene 1 (HMGN3P1) is a processed pseudogene with high sequence similarity to the functional HMGN3 gene. Pseudogenes are nonfunctional copies of genes or gene fragments that arose from duplication or retrotransposition events in the genome and generally do not encode proteins. While some pseudogenes can regulate gene expression of their parental genes through non-coding RNA mechanisms, there is no specific evidence that HMGN3P1 is functionally active or implicated in disease pathways. In contrast to true therapeutic targets, pseudogenes like HMGN3P1 are primarily studied as genomic elements with potential regulatory roles rather than druggable proteins.

02

Mechanism of action

None known or reported for drugs, since it is not a therapeutic target.

03

Biological functions

No experimentally validated biological functions for HMGN3P1. Pseudogenes generally may modulate gene expression through RNA decoys, competing endogenous RNAs (ceRNAs), or other regulatory mechanisms, but no such function is confirmed for HMGN3P1 itself.

Beyond the preview

Go deeper on High mobility group nucleosomal binding domain 3 pseudogene 1 (HMGN3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosomal binding domain 3 pseudogene 1 (HMGN3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call